We describe a new group (type 3) of the recently proposed species Mycobucteriurn celaturn isolated from eight patients with AIDS in London, England. Sequences of genes coding for 16s rRNA (EMBL accession no. 246664) showed a divergence of 17 bases from M. celuturn type 2 reference isolates and a divergence of 7 bases from M. celaturn type 1 reference isolates. A reference strain is available (NCTC 12882).
Recent developments in the genetic identification and classification of bacteria by sequencing of the genes coding for 16s rRNA (16s rDNA) (13) and other genes (5, 18) have yielded phylogenetically derived descriptions of a new group of isolates designated Mycobacteriurn celatum, within which type 1 and type 2 have been described (7) . These organisms are similar, biochemically, to the Mycobacten'um avium complex (MAC) (2), but they have unique species-specific 16s rDNA sequences and superoxide dismutase sequences ( 5 ) that indicate that they are more closely related to Mycobacterium xenopi. The differentiation of this group is important therefore because these unique sequences are not detected by commercial genomic identification systems for MAC (4) and have caused some confusion because of the similarity of the 16s rDNA sequence of Mycobacterium tuberculosis cross-reacting in some tests (3, 6, 17) . M. celatum has been reported as causing mycobacterial opportunistic infection in a small number of AIDS patients in the United States and Italy (7, 19) but not in the United Kingdom.
Fourteen isolates were recovered over a 2-year period from eight patients with AIDS in London, England, by standard clinical isolation methods (15) . One isolate was obtained from a lesion on the thumb, and one was obtained from stool; the remainder were from induced sputum, blood culture, or bronchial washing samples. Four patients had multiple isolates, and disseminated infection was indicated in six patients.
Isolates were originally distinguished by their inability to react with the AccuProbe MAC (GenProbe, Inc., San Diego, Calif.) identification kit, but they appeared biochemically indistinct from MAC. Cells were acid-fast (as determined by auramine-phenol or Ziehl-Neelsen staining) coccobacilli and did not form spores, capsules, or aerial hyphae. Visible growth on Middlebrook 7H10 agar (9) from dilute inocula could be seen after 6 to 10 days. Colonies exhibited two forms designated rough and smooth, similar to those exhibited by M. avium (1) . Colonies were initially transparent, but on prolonged culture they became creamy white and after 8 to 12 weeks they developed an intense yellow pigmentation independent of light. Growth occurred on Lowenstein-Jensen egg medium at 25, 37,42, and 44°C. Further distinguishing characteristics included negative Tween hydrolysis, negative nitrate reductase reaction, and susceptibility to thiosemicarbazone ( pg/ml in Lowenstein-Jensen medium), but colonies showed an unusually high-level 14-day arylsulfatase reaction. All isolates were sensitive to streptomycin and ethamhutol but resistant to isoniazid and rifampin as determined by the resistance ratio method (8) . The majority of isolates (12 of 14) were also sensitive to ciprofloxacin (5 pdml in Lowenstein-Jensen medium). All isolates exhibited reactions at levels below the cutoff (900 RLU) with the AccuProbe MAC identification kit. Weak false-positive reaction levels of 1,100 to 2,010 RLU were observed with AccuProbe MTB, by using a PAL (GenProbe, Inc.) luminometer, if the unbound probe hydrolysis incubation time was set at 5 min (GenProbe has subsequently recommended a 10-min hydrolysis time for all its kits). All isolates were negative with the Amplicor MTB (Roche Diagnostic Systems, Basel, Switzerland) PCR detection kit. Mycolic acid analysis of five representative isolates was performed by using protocols for thin-layer chromatographic analysis as previously described (11, 12) , and the isolates were shown to have similar two-dimensional thin-layer chromatography patterns containing a-mycolates, keto mycolates, and dicarboxylic mycolates characteristic of the MAC and M. celatum.
16s rDNA gene sequences (1,494 bp) were determined by using primers and protocols as described previously (10) . The relevant PCR products were isolated by agarose gel elcctrophoresis, excised by use of a scalpel, extracted with phenolchloroform-isoamyl alcohol, and concentrated by ethanol precipitation, and final concentrations for sequencing were estimated by a further agarose gel electrophoresis step. Automated sequencing of both strands, using 0.5 pg of product DNA, was carried out with the PRISM (14) Tug dye termination system (Perkin-Elmer, Beckensfield, United Kingdom).
16s rDNA sequences obtained from M. celaturn reference isolates (ATCC 51131T and ATCC 51130) showed eight base discrepancies with published sequences (7) (EMBL accession no. LO8 169 and L08170), especially across known compression sites (Table 1 ). All 14 clinical isolates showed identical 16s rDNA sequences which had the closest homology to the sequences derived from reference strains of M. celatum type 1 (7 base differences) and type 2 (17 base differences).
These data indicate a group of isolates which are similar to MAC in that they are able to produce prolonged disseminated infection in AIDS patients. They are also biochemically similar to MAC, differing only in that they are sensitive to streptomycin, ethambutol, and ciprofloxacin and are highly arylsulfatase positive.
There are no set guidelines, at the present time, governing the definition of mycobacterial species by using 16s rDNA gene sequence data. Diversity within these genes has also been 
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shown to be limited, when used in isolation, in differentiating closely related strains (16) . The isolates described in this study most resemble M. celatum biochemically but show minor genetic differences from the two previously described reference strains. We suggest therefore that they should be classified as M. celatum type 3. Nucleotide sequence accession number. The 16s rRNA sequence has been submitted to EMBL under accession no. 246664, and a representative strain has been placed in the National Collection of Type Cultures, Colindale, London, United Kingdom, as M. celatum type 3 NCTC 12882.
